Abbott Laboratories
ABT: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|!k | LOCK|NS!>B | LOCK|<PH@Dh |
Abbott Labs: Acquisition of Exact Sciences to Beef Up Diagnostics
Abbott announced its planned acquisition of Exact Sciences, which makes several oncology-focused tests, for roughly $21 billion, or $105 per share.
